---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-088726"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2026-08-13T12:30:26+00:00"
generated_at: "2026-08-13T12:35:27.478722+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SS Innovations Q2 revenue up 39% to $13.9M; net loss widens to $2.7M

## Summary
- Revenue $13.9M, +39.4% YoY; gross margin 50.9% vs 59.1% prior year.
- Net loss $2.7M ($0.01/share) vs $0.3M loss in Q2 2025.
- SSi Mantra installations 30 in Q2 (+30.4%); cumulative base 224 systems, 12,272 surgeries.
- H1 revenue $25.0M (+65.6%); net loss $6.2M vs $5.9M.
- FDA 510(k) decision expected by end Q1 2027; EU CE mark targeted by end 2026.

## SEC filing metadata
- accession: 0001213900-26-088726
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2026-08-13T12:30:26+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390026088726/0001213900-26-088726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390026088726/ea0301887-8k_ssinnova.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-088726
- JSON: https://secwatch.observer/filing/0001213900-26-088726.json
- Plain text: https://secwatch.observer/filing/0001213900-26-088726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.